Searchable abstracts of presentations at key conferences in endocrinology

ea0015p7 | Bone | SFEBES2008

Uncommon cause of refractory hypercalcaemia in a patient with bladder tumour

Thirumurugan Ethirajan , Clay Sarah , Knight Paul , Murray Robert

A 50-year-old man presented with a week history of feeling unwell and urinary symptoms. He was confused. His wife gave H/O 2 stone weight loss. Recent investigation for haematuria showed 3.6 cm bladder tumour. He underwent TURBT and the histology was awaited. No other significant PMH or family H/O. Not on any medication and was an ex-smoker.Initial investigations showed leucocytosis and evidence of UTI. CXR showed chronic fibrotic changes. As a part of c...

ea0015p53 | Clinical practice/governance and case reports | SFEBES2008

Hypogonadotropic hypogonadism: a consequence of Chiari-I malformation

Kumar Sampath Satish , Chumas Paul , Peckham Daniel , Murray Robert

A 24-year-old women (wt 63 kg, BMI 23) presented with history of secondary amenorrhea. Menarche occurred at age 16 years and was followed by a regular cycle (7/35). She started the combined oral contraceptive pill (OCP) at 18 years of age for menorrhagia and stopped this 16 months before her presentation, before undergoing elective surgery. Four months after discontinuing the OCP she experienced a single episode of PV bleeding, but otherwise remained amenorrhoeic. Past history...

ea0015p88 | Clinical practice/governance and case reports | SFEBES2008

Experience from the first two years of a dedicated clinic for adults with Turner syndrome

Doherty Emma , Powrie Jake , Thomas Stephen , Brackenridge Anna , Carroll Paul

Recently updated international guidelines recommend specialist surveillance of adults with Turner Syndrome (TS). In 2005, we established a dedicated TS clinic, attracting referrals from our general endocrine service and other specialities including primary care.Twenty-three patients currently attend of whom 9 were previously under endocrinology review. Karyotypes include 45XO (8/23), 45XO/46XrX (4/23), and 45XO/46XiXq (3/23). Mean (±S.D.</sma...

ea0015p127 | Diabetes, metabolism and cardiovascular | SFEBES2008

Mineralocorticoid action in essential hypertension

Hammer Fabian , Dale Jane , Ayuk John , Hobbs Richard , Stewart Paul

Primary hyperaldosteronism is now recognised as the most frequent underlying cause of hypertension. We recruited 94 patients (age (mean±S.D.) 56±11 years) with hypertension from primary care in order to study the role of corticosteroid hormone action in this cohort. Random, blood pressure (BP), plasma renin activity (PRA) and aldosterone (Aldo) was measured both on and off antihypertensive medication. In addition, a 24 h ambulatory blood pressure (ABP)...

ea0015p140 | Diabetes, metabolism and cardiovascular | SFEBES2008

Prenatal diet and postnatal metabolic function in sheep: effect of adiposity on glucose-insulin dynamics

Rhodes Philip , Loughna Paul , Rhind Stuart , Gardner David

Maternal nutrient restriction predisposes the adult offspring to metabolic syndrome. We investigated the effect of energy restriction during early or late gestation on glucose-insulin dynamics during a GTT (0.5 g/kg i.v. glucose) and/or an ITT (0.75 IU/kg) prior to and after significant gain in adipose tissue. 20 sheep were either fed to maintenance (1 M; CE, n=6) or to 0.65 M during early (0–65 days, term=147days, LEE, n=7) or late (65–125 days, LEL; <...

ea0015p151 | Diabetes, metabolism and cardiovascular | SFEBES2008

Weight loss is associated with reduced glucocorticoid production, decreased 5α-reductase activity and enhanced adipose tissue insulin sensitivity

Tomlinson Jeremy , Hughes Susan , Hughes Beverly , Stewart Paul

The epidemic of obesity, insulin resistance and type 2 diabetes has heightened the need to understand the mechanisms that contribute to their pathogenesis. Endogenous glucocorticoid (GC) production and metabolism have been implicated based upon parallels with Cushing’s syndrome. The interaction between GC metabolism and insulin sensitivity in the context of significant weight loss has not been explored. 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) that gen...

ea0015p153 | Diabetes, metabolism and cardiovascular | SFEBES2008

Depot specific differences in lipogenesis in human adipose tissue

Gathercole Laura , Bujalska Iwona , Stewart Paul , Tomlinson Jeremy

Intra-abdominal adiposity is associated with insulin resistance and increased cardiovascular morbidity and mortality. Obesity occurs as a consequence of increased adipocyte size (hypertrophy) and number (differentiation or hyperplasia). Whilst differences in gene expression between omental (om) and subcutaneous (sc) adipose tissue have been described, the molecular mechanisms that underpin the differences in adipose tissue biology and the depot specific metabolic risks that th...

ea0015p154 | Diabetes, metabolism and cardiovascular | SFEBES2008

Dehydroepiandrosterone exerts anti-glucocorticoid action on proliferation, differentiation and insulin sensitivity in human preadipocytes

McNelis Joanne , Gathercole Laura , Stewart Paul , Tomlinson Jeremy , Arlt Wiebke

The adrenal steroid dehydroepiandrosterone (DHEA) and its sulphate ester, DHEAS have been shown to oppose the effects of glucocorticoids, thereby producing beneficial effects on insulin sensitivity in rodent models of diabetes and obesity and in hypoadrenal patients. Glucocorticoids, key regulators of adipose differentiation and insulin sensitivity, are reactivated locally by 11β-hydroxysteroid dehydrogenase type (11β-HSD1) oxoreductase activity, which increases with...

ea0015p327 | Steroids | SFEBES2008

A paracrine role for 11β-hydroxysteroid dehydrogenase type 1 and glucocorticoids in the murine pancreatic islet

Swali Angelina , Tomlinson Jeremy , Walker Elizabeth , Stewart Paul

Type 2 diabetes manifests when pancreatic β-cells secrete inadequate insulin in response to elevated glucose. A known culprit in metabolic diseases is excessive exposure to glucocorticoids (GCs). GCs increase hepatic gluconeogenesis, decrease insulin sensitivity in skeletal muscle and adipose tissue and suppress the development of β-cells. In rodents, inactive GC 11-dehydrocorticosterone (A) is converted to active corticosterone (B) by the enzyme 11β-hydroxyster...

ea0014p372 | (1) | ECE2007

Predictive factors for thyroid function abnormalities in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

Cijevschi Cristina , Mihai Catalina , Zbranca Eusebie , Gogalniceanu Paul

Introduction: Chronic hepatitis C has a high incidence in our country being a major public health issue.Aims and methods: To establish prognostic factors for developing thyroid dysfunction in patients with chronic hepatitis C receiving pegylated interferon and ribavirin therapy. A prospective study of patients with chronic hepatitis C on antiviral therapy was undertaken. 68 patients started on antiviral therapy in the period 1st January 2003 – 1st J...